• 2 months ago
AstraZeneca established its vaccines unit after collaborating with the University of Oxford to develop a COVID-19 vaccine. The existing site, currently used for producing the nasal flu vaccine FluMist, is set to be upgraded under the new investment.
Transcript
00:00♪♪
00:10♪♪
00:20♪♪
00:30♪♪
00:40♪♪

Recommended